We build breakthrough biotechs

Biotech

Creating and building breakthrough biotechs for over 30 years

People

Partnering with the world's best life science entrepreneurs

Impact

Translating groundbreaking science into life-changing medicines
Scroll to explore
3
Latest news
Less than year after launch, Caldera lines up $278M financing and Nasdaq debut
Find out more
Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal
Find out more
Remix Therapeutics secures $100M and a reverse merger
Find out more

Thirty years at the leading-edge of medical innovation and we’re just getting started.

~ Measuring our impact

>25

Medicines made by Atlas portfolio companies

~ Measuring our impact

92

Startups launched from the Atlas incubator

~ Measuring our impact

43

IPOs

~ Measuring our impact

39

M&A Exits